Article

Chemotherapy and targeted therapy for advanced biliary tract cancers：An umbrella review

2022-07-27

Abstract excerpt

<h4>Background: </h4> Malignant tumors of the biliary system have high malignancy and strong invasiveness, and are usually found in late stages with poor prognosis. For patients with advanced biliary tract cancer, chemotherapy and targeted therapy are one of the options to improve prognosis and delay tumor progression. The purpose of this study was to comprehensively evaluate the safety and efficacy of various che...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4680a2bf-7096-5c85-ad56-972982073a19
DOI: 10.21203/rs.3.rs-1837266/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Chemotherapy and targeted therapy for advanced biliary tract cancers：An umbrella reviewDOI 10.21203/rs.3.rs-1837266/v1Read

Gemcitabine plus Oxaliplatin (GEMOX) combined with Atezolizumab and Bevacizumab for Advanced Biliary Tract Cancer: A Preliminary Observational StudySemantic proximity Read

Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial.Semantic proximity Read

Neoadjuvant therapy could improve survival outcomes of locally advanced biliary tract cancer by increasing opportunities for curative resection: a systematic review and meta-analysisSemantic proximity Read

Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part I: diagnosis-clinical staging and pathology.Semantic proximity Read

Systemic treatment options for advanced biliary tract carcinoma.Semantic proximity Read

Systemic treatment of advanced or recurrent biliary tract cancer.Semantic proximity Read

Rational development of combination therapies for biliary tract cancers.Semantic proximity Read

First-line hepatic arterial infusion chemotherapy plus lenvatinib and PD-(L)1 inhibitors versus systemic chemotherapy alone or with PD-(L)1 inhibitors in unresectable intrahepatic cholangiocarcinoma: a real-world studySemantic proximity Read

Exploring the impact of Durvalumab on biliary tract cancer- insights from real world clinical dataSemantic proximity Read

PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study.Semantic proximity Read

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.Semantic proximity Read

Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving ParadigmSemantic proximity Read